Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Total 13F shares
-
58,440,998
-
Share change
-
+2,483,181
-
Total reported value
-
$1,095,196,207
-
Put/Call ratio
-
112%
-
Price per share
-
$18.74
-
Number of holders
-
199
-
Value change
-
+$43,391,410
-
Number of buys
-
93
-
Number of sells
-
83
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q1 2024
As of 31 Mar 2024,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,440,998 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, RTW INVESTMENTS, LP, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Bellevue Group AG, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, and JPMORGAN CHASE & CO.
This page lists
199
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.